The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Inhibikase Therapeutics Inc shares valued at $2,000,200 were purchased by Bellini Roberto on Oct 21 ’24. At $1.37 per share, Bellini Roberto acquired 1,460,000 shares. The insider’s holdings grew to 1,460,000 shares worth approximately $3.99 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Kush Arvind purchased 145,000 shares, netting a total of over 198,650 in proceeds. Following the buying of shares at $1.37 each, the insider now holds 145,000 shares.
Before that, Munshi Amit had added 365,000 shares to its account. In a trade valued at $500,050, the Director bought Inhibikase Therapeutics Inc shares for $1.37 each. Upon closing the transaction, the insider’s holdings increased to 365,000 shares, worth approximately $1.0 million.
Analyzing IKT Stock Performance
During the last five days, there has been a surge of approximately 37.88%. Over the course of the year, Inhibikase Therapeutics Inc shares have jumped approximately 114.96%. Shares of the company reached a 52-week high of $3.82 on 01/25/24 and a 52-week low of $1.12 on 09/25/24. A 50-day SMA is recorded $1.99, while a 200-day SMA reached $1.77. Nevertheless, trading volume fell to 0.29 million shares from 0.21 million shares the previous day.
Support And Resistance Levels for Inhibikase Therapeutics Inc (IKT)
According to the 24-hour chart, there is a support level at 2.46, which, if violated, would cause prices to drop to 2.19. In the upper region, resistance lies at 2.93. The next price resistance is at 3.14. RSI (Relative Strength Index) is 63.14 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.11, which suggests the price will decrease in the coming days. Percent R is at 49.48%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
